Brief: 4E Therapeutics Acquired By Lilly To Advance Non-Opioid Approach To Chronic Pain
16/06/2026 14:32
BRIEF-4E Therapeutics Acquired By Lilly To Advance Non-Opioid Approach To Chronic Pain June 16 (Reuters) - 4E Therapeutics:
4E THERAPEUTICS ACQUIRED BY LILLY TO ADVANCE NON-OPIOID APPROACH TO CHRONIC PAIN
4E THERAPEUTICS: TERMS OF TRANSACTION WERE NOT DISCLOSED
Source text: ID:nPn38mdvSa
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eli Lilly and Co
See all newsAntares Therapeutics signs potential $1.9 billion cancer drug deal with Novartis
Absci rises on positive hair-loss drug data
China approval for Eli Lilly GLP-1 pill to come as soon as 2026, executive says
HK-listed Abbisko climbs most in 12 weeks on Eli Lilly tie-up
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly (updated)